Literature DB >> 9070222

Expression of G1-phase cell cycle genes during hematopoietic lineage.

F Della Ragione1, A Borriello, S Mastropietro, V Della Pietra, F Monno, V Gabutti, F Locatelli, L Bonsi, G P Bagnara, A Iolascon.   

Abstract

Characterization of proteins that control the passage through the G1 phase of the cell cycle is of particular interest because virtually all stimuli regulating cell proliferation or differentiation act primarily during this phase. We have analyzed the G1 phase proteic machinery, including cyclin D types, cyclin-dependent kinases (CDKs) and CDK inhibitors, of cell populations obtained at different stages of hematopoietic cell lineage. In particular, five cellular phenotypes, namely CD34+ cells (which contain stem cells), BFU-E, CFU-E, CFU-GM and peripheral lymphocytes were studied as representatives of distinct differentiation pathways. The results obtained indicated that all the cellular preparations express cyclin D2 and D3, while cyclin D1, which is the major cyclin D occurring in mesenchimal tissues, is not expressed. Moreover, CDK6 (but not CDK4) was detectable in all the populations investigated. Among the CDK inhibitors studied, p18INK4C and p19INK4D signals were clearly evidentiable in the various cell types. Interestingly, high levels of p15INK4B, a putative tumor suppressor protein, were detectable especially in granulocyte-monocyte precursors. Our results indicate that a specific hematopoietic G1 phase machinery occurs, which is conserved during the various steps of the different maturation processes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070222     DOI: 10.1006/bbrc.1997.5938

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

2.  Oncogenic stimulation recruits cyclin-dependent kinase in the cell cycle start in rat fibroblast.

Authors:  S Jinno; S C Hung; H Yamamoto; J Lin; A Nagata; H Okayama
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors.

Authors:  Mo A Dao; Joseph Hwa; Jan A Nolta
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

4.  Negative regulation of cyclin D3 expression by transcription factor c-Ets1 in umbilical cord hematopoietic cells.

Authors:  Fan-kai Meng; Han-ying Sun; Xi-you Tan; Chun-rui Li; Jian-feng Zhou; Wen-li Liu
Journal:  Acta Pharmacol Sin       Date:  2011-08-15       Impact factor: 6.150

5.  CDK6 kinase activity is required for thymocyte development.

Authors:  Miaofen G Hu; Amit Deshpande; Nicolette Schlichting; Elisabeth A Hinds; Changchuin Mao; Marei Dose; Guo-Fu Hu; Richard A Van Etten; Fotini Gounari; Philip W Hinds
Journal:  Blood       Date:  2011-04-20       Impact factor: 22.113

6.  Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation.

Authors:  Adriana Oliva; Adriana Borriello; Stefania Zeppetelli; Angelo Di Feo; Pilade Cortellazzi; Vega Ventriglia; Maria Criscuolo; Vincenzo Zappia; Fulvio Della Ragione
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

7.  Are progenitor cells pre-programmed for sequential cell cycles not requiring cyclins D and E and activation of Cdk2?

Authors:  D-X Xie; J Yao; P Zhang; X-L Li; Y-D Feng; J-H Wu; D-D Tao; J-B Hu; J-P Gong
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

8.  A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.

Authors:  Miaofen G Hu; Amit Deshpande; Miriam Enos; Daqin Mao; Elisabeth A Hinds; Guo-fu Hu; Rui Chang; Zhuyan Guo; Marei Dose; Changchuin Mao; Philip N Tsichlis; Fotini Gounari; Philip W Hinds
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

9.  Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle.

Authors:  R M Gill; P A Hamel
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

Review 10.  Targeting cell cycle regulators in hematologic malignancies.

Authors:  Eiman Aleem; Robert J Arceci
Journal:  Front Cell Dev Biol       Date:  2015-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.